High expression levels of receptor activator of nuclear factor-kappa B ligand associated with human chronic periodontitis are mainly secreted by CD4+ T lymphocytes

Journal of Periodontology

Volumn 77, Issue 10, 2006, Pages 1772-1780

  Vernal, Rolando ^a   Dutzan, Nicolás ^a   Hernández, Marcela ^a   Chandía, Sabrita ^a   Puente, Javier ^a   León, Rubén ^a   García, Leyre ^b   Del Valle, Ignacio ^b   Silva, Augusto ^b   Gamonal, Jorge ^a  

^a UNIVERSITY OF CHILE   (Chile)

^b CENTRO DE INVESTIGACIONES BIOLÓGICAS   (Spain)

Author keywords

CD4; Chronic periodontitis; Lymphocytes; RANKL; Receptor activator of nuclear factor kappa B ligand; T cells

Indexed keywords

CD4 ANTIGEN; FORMALDEHYDE; LIPOPOLYSACCHARIDE; MESSENGER RNA; OSTEOCLAST DIFFERENTIATION FACTOR; PARAFFIN; PHYTOHEMAGGLUTININ;

ADULT; AGED; ARTICLE; CD4+ T LYMPHOCYTE; CELL CULTURE; CELL INFILTRATION; CELLULAR DISTRIBUTION; CHRONIC DISEASE; CLINICAL ARTICLE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; GENE OVEREXPRESSION; GINGIVAL BIOPSY; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; PERIODONTITIS; PROTEIN LOCALIZATION; PROTEIN SECRETION; PROTEIN SYNTHESIS; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE PREPARATION;

ADULT; AGED; BIOPSY; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; CHRONIC DISEASE; FEMALE; FLOW CYTOMETRY; GINGIVA; HUMANS; LIPOPOLYSACCHARIDES; MALE; MICROSCOPY, CONFOCAL; MIDDLE AGED; MITOGENS; PERIODONTITIS; PHYTOHEMAGGLUTININS; RANK LIGAND; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 33750581476     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2006.050376     Document Type: Article

References (35)

1. Lacey DL, Timms E, Tan HL, et al. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 1998;93:165-176.
2. Blaque S, James I. RANKL (receptor activator of NFκB ligand). In: Thomson AW, Lotze MT, eds. The Cytokine Handbook, vol. 2. London: Academic Press; 2003: 871-883.
3. Takayanagi H. Inflammatory bone destruction and osteoimmunology. J Periodontal Res 2005;40:287-293.
4. Takahashi N, Udagawa N, Suda T. A new member of tumor necrosis factor ligand family, ODF/OPGL/TRANCE/RANKL, regulates osteoclast differentiation and function. Biochem Biophys Res Commun 1999; 256:449-455.
5. Hofbauer LC, Heufelder AE. Role of receptor activator of nuclear factor-κB ligand and osteoprotegerin in bone cell biology. J Mol Med 2001;79:243-253.
6. Armitage G. Development of a classification system for periodontal diseases and conditions. Ann Periodontol 1999;4:1-6.
7. Holt SC, Ebersole JL. Porphyromonas gingivalis, Treponema denticola, and Tannerella forsythia: The "red complex," a prototype polybacterial pathogenic consortium in periodontitis. Periodontol 2000 2005;38: 72-122.
8. Socransky SS, Haffajee AD. Periodontal microbial ecology. Periodontol 2000 2005;38:135-187.
9. Listgarten MA. Pathogenesis of periodontitis. J Clin Periodontol 1986;13:418-430.
10. Crotti T, Smith MD, Hirsch R, et al. Receptor activator NF-κB ligand (RANKL) and osteoprotegerin (OPG) protein expression in periodontitis. J Periodontal Res 2003;38:380-387.
11. Liu D, Xu JK, Figliomeni L, et al. Expression of RANKL and OPG mRNA in periodontal disease: Possible involvement in bone destruction. Int J Mol Med 2003; 11:17-21.
12. Mogi M, Otogoto J, Ota N, Togari A. Differential expression of RANKL and osteoprotegerin in gingival crevicular fluid of patients with periodontitis. J Dent Res 2004;83:166-169.
13. Vernal R, Chaparro A, Graumann R, Puente J, Valenzuela MA, Gamonal J. Levels of cytokine receptor activator of nuclear factor-κB ligand in gingival crevicular fluid in untreated chronic periodontitis patients. J Periodontol 2004;75:1586-1591.
14. Kong YY, Feige U, Sarosi I, et al. Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand. Nature 1999; 402:304-309.
15. Vernal R, Dutzan N, Chaparro A, Puente J, Valenzuela MA, Gamonal J. Levels of interleukin-17 in gingival crevicular fluid and in supernatants of cellular cultures of gingival tissue from patients with chronic periodontitis. J Clin Periodontol 2005;32:383-389.
16. ΔΔCt method. Methods 2001;25:402-408.
17. Weih F, Caamaño J. Regulation of secondary lymphoid organ development by the nuclear factor-κB signal transduction pathway. Immunol Rev 2003; 195:91-105.
18. Theill LE, Boyle WJ, Peninger JM. RANK-L and RANK: T cells, bone loss, and mammalian evolution. Annu Rev Immunol 2002;20:795-823.
19. Sodek J, McKee MD. Molecular and cellular biology of alveolar bone. Periodontol 2000 2000;24:99-126.
20. Huang L, Xu J, Wood DJ, Zheng MH. Gene expression of osteoprotegerin ligand, osteoprotegerin, and receptor activator of NF-kB in giant cell tumor of bone. Possible involvement in tumor cell-induced osteoclast-like cell formation. Am J Pathol 2000;156:761-767.
21. Tay JY, Bay BH, Yeo JF, Harris M, Meghji S, Dheen ST. Identification of RANKL in osteolytic lesions of the facial skeleton. J Dent Res 2004;83:349-353.
22. Hasegawa T, Yoshimura Y, Kikuiri T, et al. Expression of receptor activator of NF-kappa B ligand and osteoprotegerin in culture of human periodontal ligament cells. J Periodontal Res 2002;37:405-411.
23. Ohazama A, Courtney JM, Sharpe PT. OPG, RANK, and RANKL in tooth development: Coordination of odontogenesis and osteogenesis. J Dent Res 2004;83: 241-244.
24. Wise GE, Frazier-Bowers S, D'Souza RN. Cellular, molecular, and genetic determinants of tooth eruption. Crit Rev Oral Biol Med 2002;13:323-334.
25. Lossdörfer S, Götz W, Jäger A. Immunohistochemical localization of receptor activator of nuclear factor kappa (RANK) and its ligand (RANKL) in human deciduous teeth. Calcif Tissue Int 2002; 71:45-52.
26. Vernal R, Dezerega A, Dutzan N, et al. RANKL in human periapical granuloma: Possible involvement in periapical bone destruction. Oral Dis 2006;12:283-289.
27. Teng YT, Nguyen H, Gao X, et al. Functional human T-cell immunity and osteoprotegerin ligand control alveolar bone destruction in periodontal infection. J Clin Invest 2000;106:59-67.
28. Taubman MA, Kawai T. Involvement of T lymphocytes in periodontal disease and in direct and indirect induction of bone resorption. Crit Rev Oral Biol Med 2001;12:125-135.
29. Giulietti A, Overbergh L, Valckx D, Decallonne B, Bouillon R, Mathieu CH. An overview of real-time quantitative PCR: Applications to quantify cytokine gene expression. Methods 2001;25:386-401.
30. Thellin O, Zorzi W, Lakaye B, et al. Housekeeping genes as internal standards: Use and limits. J Biotechnol 1999;75:291-295.
31. Kreutz M, Ackermann U, Hauschildt S, et al. A comparative analysis of cytokine production and tolerance induction by bacterial lipopeptides, lipopolysaccharides and Staphylococcus aureus in human monocytes. Immunology 1997;92:396-401.
32. Abbas AK, Lichtam AH, Pober JS. Cellular and Molecular Immunology. Philadelphia: W.B. Saunders; 2000:161-182.
33. Zachrisson BU. A histologic study of experimental gingivitis in man. J Periodontal Res 1968;3:293-302.
34. Payne WA, Page RC, Ogilvie AI, Hall WB. Histopathologic features of the initial and early stages of experimental gingivitis in man. J Periodontal Res 1975;10:51-64.
35. Seymour GJ, Powell RN, Cole KL, et al. Experimental gingivitis in humans. A histochemical and immunological characterization of the lymphoid cell subpopulations. J Periodontal Res 1983;18:375-385.